Skip to main content

XOSPATA Presentation

When

07/22/21    
12:00 pm - 1:00 pm

XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients (077-0621-PM)

PRESENTER

Catherine Lai, M.D., M.P.H.
Medstar Georgetown University Hospital; Lombardi Comprehensive Cancer Center; Georgetown University Medical Center
Washington, DC

 

RSVP by July 15 To:

https://astellas.virtualspeakercast.net/Registration/index/275

Phone:   973-930-3192

Email: melba.vasquez@astellas.com

Register at https://astellas.virtualspeakercast.net/Registration/index/275

A confirmation will then be sent to you with the program web link and call-in number